Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.

Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY, Copeland G, Saber MS, Hopenhayn C, Huang Y, Cozen W, Lyu C, Unger ER; HPV Typing of Cancers Workgroup.

Emerg Infect Dis. 2014 May;20(5):822-8. doi: 10.3201/eid2005.131311.

2.

US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.

Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT; HPV Typing of Cancers Workgroup.

J Natl Cancer Inst. 2015 Apr 29;107(6):djv086. doi: 10.1093/jnci/djv086. Print 2015 Jun.

3.

Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.

Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, Anderson RN, Yankey D, Edwards BK.

J Natl Cancer Inst. 2013 Feb 6;105(3):175-201. doi: 10.1093/jnci/djs491. Epub 2013 Jan 7.

4.

The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry.

Cleveland JL, Junger ML, Saraiya M, Markowitz LE, Dunne EF, Epstein JB.

J Am Dent Assoc. 2011 Aug;142(8):915-24. Review. Erratum in: J Am Dent Assoc. 2011 Sep;142(9):1005-6.

PMID:
21804058
5.

Human papillomavirus-associated cancers - United States, 2004-2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Apr 20;61:258-61.

6.

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?

Osazuwa-Peters N.

Vaccine. 2013 Nov 12;31(47):5500-5. doi: 10.1016/j.vaccine.2013.09.031. Epub 2013 Oct 3. Review.

PMID:
24095883
7.

Cancers attributable to human papillomavirus infection.

Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.

Sex Health. 2010 Sep;7(3):244-52. doi: 10.1071/SH10020.

PMID:
20719211
8.

Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

Gillison ML.

J Adolesc Health. 2008 Oct;43(4 Suppl):S52-60. doi: 10.1016/j.jadohealth.2008.07.002. Review.

9.

HPV vaccination. Inaccurate assumptions about oropharyngeal cancer.

Sturgis EM, Dahlstrom KR.

BMJ. 2009 Nov 2;339:b4525. doi: 10.1136/bmj.b4525. No abstract available.

PMID:
19884209
10.

Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML.

J Clin Oncol. 2011 Nov 10;29(32):4294-301. doi: 10.1200/JCO.2011.36.4596. Epub 2011 Oct 3.

11.

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.

Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJ, Berkhof J.

BMJ. 2015 May 12;350:h2016. doi: 10.1136/bmj.h2016.

12.

Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.

Hong AM, Grulich AE, Jones D, Lee CS, Garland SM, Dobbins TA, Clark JR, Harnett GB, Milross CG, O'Brien CJ, Rose BR.

Vaccine. 2010 Apr 26;28(19):3269-72. doi: 10.1016/j.vaccine.2010.02.098. Epub 2010 Mar 10.

PMID:
20226244
14.

Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.

Jain KS, Sikora AG, Baxi SS, Morris LG.

Cancer. 2013 May 15;119(10):1832-7. doi: 10.1002/cncr.27988. Epub 2013 Feb 19.

15.

Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.

Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K.

Cancer. 2008 Nov 15;113(10 Suppl):2901-9. doi: 10.1002/cncr.23745.

16.

Extended coverage of HPV vaccination in middle-aged adults to prevent oropharyngeal cancers.

Arya SC, Agarwal N.

Hum Vaccin Immunother. 2012 Jul;8(7):959. doi: 10.4161/hv.20043. Epub 2012 Jul 1. No abstract available.

PMID:
22777098
17.

Public awareness of human papillomavirus as a causative factor for oropharyngeal cancer.

Williams MU, Carr MM, Goldenberg D.

Otolaryngol Head Neck Surg. 2015 Jun;152(6):1029-34. doi: 10.1177/0194599815577781. Epub 2015 Mar 27.

PMID:
25820579
18.

Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.

Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB.

Cancer. 2008 Nov 15;113(10 Suppl):2841-54. doi: 10.1002/cncr.23758.

19.

Low prevalence of human papillomavirus in oral cavity carcinomas.

Machado J, Reis PP, Zhang T, Simpson C, Xu W, Perez-Ordonez B, Goldstein DP, Brown DH, Gilbert RW, Gullane PJ, Irish JC, Kamel-Reid S.

Head Neck Oncol. 2010 Mar 12;2:6. doi: 10.1186/1758-3284-2-6.

20.

Beyond cervical cancer: burden of other HPV-related cancers among men and women.

Chaturvedi AK.

J Adolesc Health. 2010 Apr;46(4 Suppl):S20-6. doi: 10.1016/j.jadohealth.2010.01.016.

PMID:
20307840
Items per page

Supplemental Content

Write to the Help Desk